Cargando…

Following the Fate of Dye-Containing Liposomes In Vitro

The rather limited success of translation from basic research to clinical application has been highlighted as a major issue in the nanomedicine field. To identify the factors influencing the applicability of nanosystems as drug carriers and potential nanomedicine, we focused on following their fate...

Descripción completa

Detalles Bibliográficos
Autores principales: Cauzzo, Jennifer, Nystad, Mona, Holsæter, Ann Mari, Basnet, Purusotam, Škalko-Basnet, Nataša
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402323/
https://www.ncbi.nlm.nih.gov/pubmed/32659908
http://dx.doi.org/10.3390/ijms21144847
_version_ 1783566734386528256
author Cauzzo, Jennifer
Nystad, Mona
Holsæter, Ann Mari
Basnet, Purusotam
Škalko-Basnet, Nataša
author_facet Cauzzo, Jennifer
Nystad, Mona
Holsæter, Ann Mari
Basnet, Purusotam
Škalko-Basnet, Nataša
author_sort Cauzzo, Jennifer
collection PubMed
description The rather limited success of translation from basic research to clinical application has been highlighted as a major issue in the nanomedicine field. To identify the factors influencing the applicability of nanosystems as drug carriers and potential nanomedicine, we focused on following their fate through fluorescence-based assays, namely flow cytometry and imaging. These methods are often used to follow the nanocarrier internalization and targeting; however, the validity of the obtained results strictly depends on how much the nanosystem’s fate can be inferred from the fate of fluorescent dyes. To evaluate the parameters that affect the physicochemical and biological stability of the labeled nanosystems, we studied the versatility of two lipid dyes, TopFluor(®)-PC and Cy5-DSPE, in conventional liposomes utilizing well-defined in vitro assays. Our results suggest that the dye can affect the major characteristics of the system, such as vesicle size and zeta-potential. However, a nanocarrier can also affect the dye properties. Medium, temperature, time, fluorophore localization and its concentration, as well as their interplay, affect the outcome of tracing experiments. Therefore, an in-depth characterization of the labeled nanosystem should be fundamental to understand the conditions that validate the results within the screening process in optimization of nanocarrier.
format Online
Article
Text
id pubmed-7402323
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74023232020-08-18 Following the Fate of Dye-Containing Liposomes In Vitro Cauzzo, Jennifer Nystad, Mona Holsæter, Ann Mari Basnet, Purusotam Škalko-Basnet, Nataša Int J Mol Sci Article The rather limited success of translation from basic research to clinical application has been highlighted as a major issue in the nanomedicine field. To identify the factors influencing the applicability of nanosystems as drug carriers and potential nanomedicine, we focused on following their fate through fluorescence-based assays, namely flow cytometry and imaging. These methods are often used to follow the nanocarrier internalization and targeting; however, the validity of the obtained results strictly depends on how much the nanosystem’s fate can be inferred from the fate of fluorescent dyes. To evaluate the parameters that affect the physicochemical and biological stability of the labeled nanosystems, we studied the versatility of two lipid dyes, TopFluor(®)-PC and Cy5-DSPE, in conventional liposomes utilizing well-defined in vitro assays. Our results suggest that the dye can affect the major characteristics of the system, such as vesicle size and zeta-potential. However, a nanocarrier can also affect the dye properties. Medium, temperature, time, fluorophore localization and its concentration, as well as their interplay, affect the outcome of tracing experiments. Therefore, an in-depth characterization of the labeled nanosystem should be fundamental to understand the conditions that validate the results within the screening process in optimization of nanocarrier. MDPI 2020-07-09 /pmc/articles/PMC7402323/ /pubmed/32659908 http://dx.doi.org/10.3390/ijms21144847 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cauzzo, Jennifer
Nystad, Mona
Holsæter, Ann Mari
Basnet, Purusotam
Škalko-Basnet, Nataša
Following the Fate of Dye-Containing Liposomes In Vitro
title Following the Fate of Dye-Containing Liposomes In Vitro
title_full Following the Fate of Dye-Containing Liposomes In Vitro
title_fullStr Following the Fate of Dye-Containing Liposomes In Vitro
title_full_unstemmed Following the Fate of Dye-Containing Liposomes In Vitro
title_short Following the Fate of Dye-Containing Liposomes In Vitro
title_sort following the fate of dye-containing liposomes in vitro
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402323/
https://www.ncbi.nlm.nih.gov/pubmed/32659908
http://dx.doi.org/10.3390/ijms21144847
work_keys_str_mv AT cauzzojennifer followingthefateofdyecontainingliposomesinvitro
AT nystadmona followingthefateofdyecontainingliposomesinvitro
AT holsæterannmari followingthefateofdyecontainingliposomesinvitro
AT basnetpurusotam followingthefateofdyecontainingliposomesinvitro
AT skalkobasnetnatasa followingthefateofdyecontainingliposomesinvitro